Cancer
The latest news on cancer diagnostics, liquid biopsy, and cancer risk testing.
Yourgene Inks Deal With EKF Diagnostics to Offer NIPT, Other Genomic Tests in US
Under the terms of the deal, EKF subsidiary Advanced Diagnostics Laboratory will offer an NIPT service in the US based on Yourgene's technology.
Interpace Commences $30M Rights Offering
The company said the offering will help raise capital while allowing existing shareholders to maintain their proportional ownership in the company.
Invitae Launches Ciitizen Genome Information Management Platform at JPM
The company believes the platform will expedite its longstanding goal of amassing genomic and other information from patients through their lifespan to fuel discoveries and improve care.
The UK company expects the pyrophosphorolysis-based technology to have cost and convenience advantages over sequencing-based assays.
PreciseDx Raises $10.75M in Series A Round
The company is developing a cancer risk stratification technology that combines tissue-derived morphology information with clinical data.